Based on data from more than 20,000 patients with a hepatitis C cure, the study took two years to complete and involved 31 experts from around theNew medications called direct acting antivirals were developed in 2011 and now more than 95% of patients treated with DAAs achieve a ‘virological cure’ and have a significantly lower risk of death than untreated patients.
The study’s principal investigator Dr Hamish Innes, Senior Research Fellow in the University’s School ofand Life Sciences’ Research Centre for Health , said: “Our research shows that cured patients continue to face very high mortality rates after achieving a hepatitis C cure, driven by liver and drug-related causes.
He added: “The question is - what can we do to pre-empt this? Hepatitis C treatment is an opportune time to address competing health problems, including alcohol and drug use, and to establish life-saving screening for liver cancer.“We should be doing much more to support patients after cure. Otherwise, when we look back in years to come, we may see hepatitis C elimination not only as a great achievement, but as a great missed opportunity too.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Glasgow_Live - 🏆 4. / 97 Read more »
Source: Glasgow_Live - 🏆 4. / 97 Read more »
Source: Glasgow_Live - 🏆 4. / 97 Read more »